Altogether, silencing GM-CSF in Smad3 knockout NK cells remarkably mitigated the therapeutic effects of Smad3 knockout NK cell therapy, highlighting the significance of GM-CSF in NK-mediated anti-cancer effects. The gene discussed is CSF2; the disease is cancer.